Evaluating Efficacy and Safety of IL-17 Inhibitors in Clinical Practice

This chapter explores the effectiveness and safety of various IL-17 inhibitors in clinical practice, with an emphasis on treatment switches during patient flare-ups. It also discusses the promising results from a study on bimikizumab and outlines the significance of future research, including the B-BOLD trial, in optimizing biologic therapy choices.